Brief: DocGo Q4 Revenue USD 199.2 Million Vs. IBES Estimate USD 194.2 Million
Feb 28 (Reuters) - DocGo Q4 gross margin 33.5%. * Q4 net income USD 8 million vs. IBES estimate USD 10.3 million * Q4 adjusted EBITDA USD 22.6 million vs. IBES estimate USD 20.7 million * outlook FY adjusted EBITDA USD 80-85 million
Recent news on DocGo
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
U.S. STOCKS ON THE MOVE-Dynatrace, Duolingo, Baidu Inc
DocGo slips on tepid quarterly results, narrower annual outlook